Micreos gladskin US

Micreos, a Dutch phage biotech company, secured 30 million Euro last month for its phage lysin technology. The company plans to use the funds for lysin development, and to launch its over-the-counter Gladskin product (anti-Staph aureus lysin product for treating eczema, acne and rosacea) in the US.